Ana
López Martín
Hospital Severo Ochoa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Severo Ochoa (12)
2024
-
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
British Journal of Cancer, Vol. 130, Núm. 3, pp. 417-424
2023
-
Effects of Physical Activity Interventions on Self-Perceived Health Status among Lung Cancer Patients: Systematic Review and Meta-Analysis
Cancers, Vol. 15, Núm. 23
-
Immunogenicity of COVID-19 vaccines in lung cancer patients
Lung Cancer, Vol. 184
-
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e166-e174
2022
-
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Translational Lung Cancer Research, Vol. 11, Núm. 1, pp. 53-63
2021
-
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial
Molecular Oncology, Vol. 15, Núm. 1, pp. 43-56
-
Lung cancer patients with COVID-19 in Spain: GRAVID study
Lung Cancer, Vol. 157, pp. 109-115
2017
-
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial
Journal of Thoracic Oncology, Vol. 12, Núm. 4, pp. 752-762
2016
-
Multidisciplinary approach of unresectable head and neck cancer
Head and Neck Cancer: Multimodality Management, Second Edition (Springer International Publishing), pp. 617-624
-
Targeted therapy in locally advanced and recurrent/metastatic head and neck squamous cell carcinoma (LA-R/M HNSCC)
Cancers, Vol. 8, Núm. 3
2012
-
Toxicidad pulmonar grave relacionada con la administración de gemcitabina
Farmacia Hospitalaria
2007
-
Prognostic value of KIT expression in small cell lung cancer
Lung Cancer, Vol. 56, Núm. 3, pp. 405-413